Tandem Diabetes Care
TNDM
Performance
About Tandem Diabetes Care
Tandem Diabetes Care develops insulin pumps and related products and services designed to improve diabetes management. The company offers automated insulin delivery systems, CGM integration, and accompanying software and mobile apps across multiple countries, with a focus on pediatric and adult users. Its devices emphasize convenience, user-friendly interfaces, and remote software updates, targeting people living with diabetes and the healthcare providers who support them.
Recent News
Omnipod 6 Improves Time in Range Compared with Omnipod 5
The Paradigm Shift in Metabolic Health: Dexcom’s Strategic Acquisition of Nutrisense and the Convergence of Biosensing, AI and Coaching
FDA Approves Automated Insulin Delivery System for Pregnancy
Photon Just Killed the “E” In E-Prescribing
5 Diabetes Tech Gadgets Showing How AI Is Changing Glucose Monitoring
3 Takeaways From ADA
Europa Distribution Wraps the Sixth EDMentorShe Programme - Industry / Market - Europe
Beta Bionics to Launch Its First Insulin Patch Pump to Compete with Insulet
FDA Clears Tandem’s Control‑IQ+ Closed‑Loop System for Pregnant Women with Type 1 Diabetes
We Need A Proper AI Inference Benchmark Test
Forus Raises US$160m for AI-Powered Medicine Platform
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
MiniMed IPO Points to Smarter Diabetes Devices
19 US Cities Every Foodie Should Have On Their Bucket List
Tandem to File Tubeless Insulin Pump with FDA This Quarter
Insulet Launches Pivotal Trial of Fully Closed‑Loop Insulin System for Type 2 Diabetes
Multiple CGM Sensors May Be Used with Automated Insulin Delivery
Regulatory Actions for June 8, 2026
Tandem Recalls Mobi Insulin Pumps over Software Malfunction
Recent Deals
No recent deals for this company.